Literature DB >> 25404359

Granzyme B-activated p53 interacts with Bcl-2 to promote cytotoxic lymphocyte-mediated apoptosis.

Thouraya Ben Safta1, Linda Ziani1, Loetitia Favre1, Lucille Lamendour1, Gwendoline Gros1, Fathia Mami-Chouaib1, Denis Martinvalet2, Salem Chouaib1, Jerome Thiery3.   

Abstract

Granzyme B (GzmB) plays a major role in CTLs and NK cell-mediated elimination of virus-infected cells and tumors. Human GzmB preferentially induces target cell apoptosis by cleaving the proapoptotic Bcl-2 family member Bid, which, together with Bax, induces mitochondrial outer membrane permeabilization. We previously showed that GzmB also induces a rapid accumulation of the tumor-suppressor protein p53 within target cells, which seems to be involved in GzmB-induced apoptosis. In this article, we show that GzmB-activated p53 accumulates on target cell mitochondria and interacts with Bcl-2. This interaction prevents Bcl-2 inhibitory effect on both Bax and GzmB-truncated Bid, and promotes GzmB-induced mitochondrial outer membrane permeabilization. Consequently, blocking p53-Bcl-2 interaction decreases GzmB-induced Bax activation, cytochrome c release from mitochondria, and subsequent effector caspases activation leading to a decreased sensitivity of target cells to both GzmB and CTL/NK-mediated cell death. Together, our results define p53 as a new important player in the GzmB apoptotic signaling pathway and in CTL/NK-induced apoptosis.
Copyright © 2014 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25404359     DOI: 10.4049/jimmunol.1401978

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  16 in total

1.  Antibody-based redirection of universal Fabrack-CAR T cells selectively kill antigen bearing tumor cells.

Authors:  Yi-Chiu Kuo; Cheng-Fu Kuo; Kurt Jenkins; Alfur Fu-Hsin Hung; Wen-Chung Chang; Miso Park; Brenda Aguilar; Renate Starr; Jonathan Hibbard; Christine Brown; John C Williams
Journal:  J Immunother Cancer       Date:  2022-06       Impact factor: 12.469

Review 2.  New insights into the role of EMT in tumor immune escape.

Authors:  Stéphane Terry; Pierre Savagner; Sandra Ortiz-Cuaran; Linda Mahjoubi; Pierre Saintigny; Jean-Paul Thiery; Salem Chouaib
Journal:  Mol Oncol       Date:  2017-06-27       Impact factor: 6.603

3.  Melanoma-associated fibroblasts decrease tumor cell susceptibility to NK cell-mediated killing through matrix-metalloproteinases secretion.

Authors:  Linda Ziani; Thouraya Ben Safta-Saadoun; Johanne Gourbeix; Andrea Cavalcanti; Caroline Robert; Gilles Favre; Salem Chouaib; Jerome Thiery
Journal:  Oncotarget       Date:  2017-03-21

4.  Endoplasmic Reticulum Stress Mediates Methamphetamine-Induced Blood-Brain Barrier Damage.

Authors:  Xiaojuan Qie; Di Wen; Hongyan Guo; Guanjie Xu; Shuai Liu; Qianchao Shen; Yi Liu; Wenfang Zhang; Bin Cong; Chunling Ma
Journal:  Front Pharmacol       Date:  2017-09-14       Impact factor: 5.810

5.  Correlate the TP53 Mutation and the HRAS Mutation with Immune Signatures in Head and Neck Squamous Cell Cancer.

Authors:  Haoyu Lyu; Mengyuan Li; Zehang Jiang; Zhixian Liu; Xiaosheng Wang
Journal:  Comput Struct Biotechnol J       Date:  2019-07-26       Impact factor: 7.271

6.  Anisotropic Platinum Nanoparticle-Induced Cytotoxicity, Apoptosis, Inflammatory Response, and Transcriptomic and Molecular Pathways in Human Acute Monocytic Leukemia Cells.

Authors:  Sangiliyandi Gurunathan; Muniyandi Jeyaraj; Hyeonwoo La; Hyunjin Yoo; Youngsok Choi; Jeong Tae Do; Chankyu Park; Jin-Hoi Kim; Kwonho Hong
Journal:  Int J Mol Sci       Date:  2020-01-09       Impact factor: 5.923

7.  The tissue dependent interactions between p53 and Bcl-2 in vivo.

Authors:  Xin Li; Xiao Miao; Hongshen Wang; Zhixiang Xu; Bin Li
Journal:  Oncotarget       Date:  2015-11-03

8.  Neuroprotective effects of sodium hydrosulfide against β-amyloid-induced neurotoxicity.

Authors:  Xiao-Hui Li; Yuan-Yuan Deng; Fei Li; Jing-Shan Shi; Qi-Hai Gong
Journal:  Int J Mol Med       Date:  2016-08-09       Impact factor: 4.101

9.  Combination with SGT-53 overcomes tumor resistance to a checkpoint inhibitor.

Authors:  Sang-Soo Kim; Joe B Harford; Manish Moghe; Antonina Rait; Esther H Chang
Journal:  Oncoimmunology       Date:  2018-08-01       Impact factor: 8.110

10.  The pharmalogical reactivation of p53 function improves breast tumor cell lysis by granzyme B and NK cells through induction of autophagy.

Authors:  Marie Chollat-Namy; Thouraya Ben Safta-Saadoun; Djazia Haferssas; Guillaume Meurice; Salem Chouaib; Jerome Thiery
Journal:  Cell Death Dis       Date:  2019-09-20       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.